£900K
TwinPath Ventures led the pre-seed round to help accelerate regulatory clearance and clinical validation for the company's sepsis prediction software.
AM
Aisthesis Medical
Aisthesis Medical develops hospital-grade artificial intelligence software to predict and prevent life-threatening clinical conditions.
United Kingdom—Founded 2022
£900KTotal raised
Aisthesis Medical develops hospital-grade artificial intelligence software designed to predict and prevent life-threatening medical conditions. Its primary platform, VIOSync SPI, helps clinicians anticipate in-hospital sepsis development.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Aisthesis Medical's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
IG
VD
Vasilis Dimakopoulos
Vasilis is the founder and Chief Scientific Officer at Aisthesis Medical. He previously held research and data science roles at Universitätsspital Zürich, the University of Zurich, and the AO Foundation.
SL
Sotiris Liliopoulos